Nebulized Bupivacaine Analgesia for Cleft Palate Repair
Status:
Recruiting
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
In this study we introduce a potent local anesthetic; bupivacaine 0.5% in two different doses
by nebulization as a preemptive analgesia to compare efficacy and safety in children with
cleft palate repair.